Report Detail

Other Global HER2 Antibodies Market Size, Status and Forecast 2019-2025

  • RnM3466701
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 pages
  • |
  • QYResearch
  • |
  • Other

Global HER2 Antibodies Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global HER2 Antibodies Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Trastuzumab
      • 1.4.3 Lapatinib
      • 1.4.4 Ado-trastuzumab emtansine
      • 1.4.5 Pertuzumab
      • 1.4.6 Everolimus
    • 1.5 Market by Application
      • 1.5.1 Global HER2 Antibodies Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 E-commerce
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 HER2 Antibodies Market Size
    • 2.2 HER2 Antibodies Growth Trends by Regions
      • 2.2.1 HER2 Antibodies Market Size by Regions (2014-2025)
      • 2.2.2 HER2 Antibodies Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 HER2 Antibodies Market Size by Manufacturers
      • 3.1.1 Global HER2 Antibodies Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global HER2 Antibodies Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global HER2 Antibodies Market Concentration Ratio (CR5 and HHI)
    • 3.2 HER2 Antibodies Key Players Head office and Area Served
    • 3.3 Key Players HER2 Antibodies Product/Solution/Service
    • 3.4 Date of Enter into HER2 Antibodies Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global HER2 Antibodies Market Size by Type (2014-2019)
    • 4.2 Global HER2 Antibodies Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States HER2 Antibodies Market Size (2014-2019)
    • 5.2 HER2 Antibodies Key Players in United States
    • 5.3 United States HER2 Antibodies Market Size by Type
    • 5.4 United States HER2 Antibodies Market Size by Application

    6 Europe

    • 6.1 Europe HER2 Antibodies Market Size (2014-2019)
    • 6.2 HER2 Antibodies Key Players in Europe
    • 6.3 Europe HER2 Antibodies Market Size by Type
    • 6.4 Europe HER2 Antibodies Market Size by Application

    7 China

    • 7.1 China HER2 Antibodies Market Size (2014-2019)
    • 7.2 HER2 Antibodies Key Players in China
    • 7.3 China HER2 Antibodies Market Size by Type
    • 7.4 China HER2 Antibodies Market Size by Application

    8 Japan

    • 8.1 Japan HER2 Antibodies Market Size (2014-2019)
    • 8.2 HER2 Antibodies Key Players in Japan
    • 8.3 Japan HER2 Antibodies Market Size by Type
    • 8.4 Japan HER2 Antibodies Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia HER2 Antibodies Market Size (2014-2019)
    • 9.2 HER2 Antibodies Key Players in Southeast Asia
    • 9.3 Southeast Asia HER2 Antibodies Market Size by Type
    • 9.4 Southeast Asia HER2 Antibodies Market Size by Application

    10 India

    • 10.1 India HER2 Antibodies Market Size (2014-2019)
    • 10.2 HER2 Antibodies Key Players in India
    • 10.3 India HER2 Antibodies Market Size by Type
    • 10.4 India HER2 Antibodies Market Size by Application

    11 Central & South America

    • 11.1 Central & South America HER2 Antibodies Market Size (2014-2019)
    • 11.2 HER2 Antibodies Key Players in Central & South America
    • 11.3 Central & South America HER2 Antibodies Market Size by Type
    • 11.4 Central & South America HER2 Antibodies Market Size by Application

    12 International Players Profiles

    • 12.1 Novartis
      • 12.1.1 Novartis Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 HER2 Antibodies Introduction
      • 12.1.4 Novartis Revenue in HER2 Antibodies Business (2014-2019)
      • 12.1.5 Novartis Recent Development
    • 12.2 Pfizer
      • 12.2.1 Pfizer Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 HER2 Antibodies Introduction
      • 12.2.4 Pfizer Revenue in HER2 Antibodies Business (2014-2019)
      • 12.2.5 Pfizer Recent Development
    • 12.3 Roche
      • 12.3.1 Roche Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 HER2 Antibodies Introduction
      • 12.3.4 Roche Revenue in HER2 Antibodies Business (2014-2019)
      • 12.3.5 Roche Recent Development
    • 12.4 Abnova
      • 12.4.1 Abnova Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 HER2 Antibodies Introduction
      • 12.4.4 Abnova Revenue in HER2 Antibodies Business (2014-2019)
      • 12.4.5 Abnova Recent Development
    • 12.5 InvivoGen
      • 12.5.1 InvivoGen Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 HER2 Antibodies Introduction
      • 12.5.4 InvivoGen Revenue in HER2 Antibodies Business (2014-2019)
      • 12.5.5 InvivoGen Recent Development
    • 12.6 Celltrion
      • 12.6.1 Celltrion Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 HER2 Antibodies Introduction
      • 12.6.4 Celltrion Revenue in HER2 Antibodies Business (2014-2019)
      • 12.6.5 Celltrion Recent Development
    • 12.7 Biocon
      • 12.7.1 Biocon Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 HER2 Antibodies Introduction
      • 12.7.4 Biocon Revenue in HER2 Antibodies Business (2014-2019)
      • 12.7.5 Biocon Recent Development
    • 12.8 Novus Biologicals
      • 12.8.1 Novus Biologicals Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 HER2 Antibodies Introduction
      • 12.8.4 Novus Biologicals Revenue in HER2 Antibodies Business (2014-2019)
      • 12.8.5 Novus Biologicals Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer.

      In 2018, the global HER2 Antibodies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global HER2 Antibodies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HER2 Antibodies development in United States, Europe and China.

      The key players covered in this study
      Novartis
      Pfizer
      Roche
      Abnova
      InvivoGen
      Celltrion
      Biocon
      Novus Biologicals

      Market segment by Type, the product can be split into
      Trastuzumab
      Lapatinib
      Ado-trastuzumab emtansine
      Pertuzumab
      Everolimus

      Market segment by Application, split into
      Hospital Pharmacies
      Retail Pharmacies
      E-commerce

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global HER2 Antibodies status, future forecast, growth opportunity, key market and key players.
      To present the HER2 Antibodies development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of HER2 Antibodies are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on HER2 Antibodies. Industry analysis & Market Report on HER2 Antibodies is a syndicated market report, published as Global HER2 Antibodies Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of HER2 Antibodies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,137.42
      4,706.13
      6,274.83
      3,474.24
      5,211.36
      6,948.48
      421,777.20
      632,665.80
      843,554.40
      268,194.03
      402,291.05
      536,388.06
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report